The Rogosin Institute
505 East 70th Street
New York, NY 10021
WWW.ROGOSIN.ORG (212) 746-1552

Rogosin facility addresses:

Rogosin Kidney Center
505 East 70th Street
New York, NY 10021

Manhattan Dialysis Center
505 East 70th Street
New York, NY 10021

Queens Dialysis Center
66-20 Queens Boulevard
Woodside, NY 11377

Auburndale Dialysis Center
39-20 Utopia Parkway
Flushing, NY 11358

Brooklyn Dialysis Center
506 Sixth Street
Brooklyn, NY 11215

Comprehensive Lipid Control Center
505 East 70th Street, 2nd floor
New York, NY 10021

Immunogenetics and Transplantation Laboratory
432 East 71 Street
New York, NY 10021

The Rogosin Institute Laboratory
New York Blood Center
310 East 67th Street
New York, NY 10065

The Rogosin Institute is a medical treatment and research facility affiliated with NewYork-Presbyterian Hospital and Weill Cornell Medical College and is a member of the NewYork-Presbyterian Healthcare System.

The Institute has specialty treatment programs for acute and chronic kidney disease, including all forms of dialysis and transplantation. Rogosin also has a Polycystic Kidney Disease Center and the Hypertension Center located in Manhattan. Dialysis units are located in: Manhattan, Queens and Brooklyn (see addresses below).

The Rogosin Institute performs over 100,000 dialyses treatments annually at its Manhattan and satellite centers. The Institute began the first program for home nocturnal hemodialysis in the metropolitan area with remote monitoring for conventional dialysis machines and NxStage dialysis machines and has one of the largest peritoneal dialysis programs.

A leader in kidney transplantation, Rogosin, in collaboration with NewYork-Presbyterian Hospital/Weill Cornell, performed its 3000th kidney transplant in 2007 and performs over 200 transplants each year. The transplant program benefits from Rogosin's world-renowned Immunogenetics and Transplantation Laboratory that provides tissue typing and cross-matching for its transplant program and five others in the New York City area.

The Institute's Comprehensive Lipid Control Center provides treatment of cardiovascular disease related to cholesterol and other lipid disorders for adults and children and pioneered LDL-apheresis as a treatment for familial hypercholesterolemia. Rogosin also helped initiate liver transplantation for pediatric patients with familial hypercholesterolemia.

The Rogosin Institute conducts basic and clinical research programs in kidney disease and cardiovascular disease with an extensive research program in porcine islet cell transplantation for diabetes. Rogosin also has a novel treatment for cancer and has a clinical research program using this treatment.

Rogosin also has a Clinical Research Laboratory.

Rogosin has 370 employees including 20 physicians, three Ph.D.s and six nurse practitioners.

DISCLAIMER